InNexus Biotechnology CEO Named Business Leader of the Year
November 17 2008 - 7:59AM
PR Newswire (US)
BRITISH COLUMBIA, Canada, Nov. 17 /PRNewswire-FirstCall/ -- InNexus
Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS;
http://www.ixsbio.com/), a drug development company commercializing
the next generation of monoclonal antibodies based on its Dynamic
Cross Linking (DXL) technology, announced today that the Arizona
Technology Council, in partnership with the Arizona Department of
Commerce and in conjunction with Arizona Governor Janet Napolitano,
named Jeff Morhet, Chairman and CEO, as the Ed Denison Business
Leader of the Year at the 2008 Governor's Celebration of Innovation
Awards event, which was held on 13 November 2008 at the Dodge
Theatre in downtown Phoenix, Arizona. The Ed Denison Business
Leader of the Year Award is presented to an individual who
contributes to Arizona's technology industry through sustained
growth of their business or company. To be nominated for and
receive this award, an individual must be in a leadership position
employed by an Arizona-based business or division of a corporation
operating in Arizona, and must have resided in Arizona for at least
five years. Leadership qualities such as entrepreneurship,
community involvement, and management expertise are considered.
"I'm humbled and honored to be recognized by the community and
receive this year's Ed Denison Business Leader of the Year Award,"
said Morhet. "I am thankful for the support of my family, peers and
the InNexus team, who have made this award possible.
Congratulations also to the other award winners and finalists."
About the Governor's Celebration of Innovation The Governor's
Celebration of Innovation was established in 2003 by combining two
technology award ceremonies: the High Tech Industry Cluster's
17-year Innovator of the Year awards ceremony and the Arizona
Software and Internet Association's 10-year "Celebration of
Innovation." With the addition of the Governor's support, the
Governor's Celebration of Innovation has become the premier
technology community gathering of its kind in Arizona. About the
Arizona Technology Council The Arizona Technology Council is a
private, not-for-profit trade association founded to connect,
represent and support the state's expanding technology industry. To
promote economic growth and professional development in Arizona's
technology sector, the Council provides members networking
opportunities, business support and access to educational forums.
The Council strives to distinguish Arizona as a leader in the
technology community and offer resources that are exclusive to its
members. For more information, please visit
http://www.aztechcouncil.org/. About InNexus InNexus is a drug
development company commercializing the next generation of
monoclonal antibodies based on its DXL technology, which improves
the potency of existing antibody products while opening new markets
and disease applications. DXL antibodies utilize unique, novel and
patented methods and technologies of InNexus. InNexus is
headquartered in British Columbia with principal management based
in Scottsdale, Arizona on the campus of Mayo Clinic and has its own
in-house developmental facilities. These development resources
provide validation of protein and peptide discoveries, enabling
InNexus (and its strategic partners) to advance novel drug
therapeutics and diagnostics. To learn more about InNexus, please
visit http://www.ixsbio.com/. The TSX Venture Exchange has not
reviewed and does not accept responsibility for the adequacy or
accuracy of this news release. This news release may contain
assumptions, estimates, and other forward-looking statements that
involve inherent risks and uncertainties and are subject to
factors, many of which are beyond the Company's control, which may
cause actual results or performance to differ materially from those
currently anticipated in such statements. DATASOURCE: InNexus
Biotechnology Inc. CONTACT: Jeff Morhet, Chairman and Chief
Executive Officer of InNexus Biotechnology Inc., +1-480-862-7500
Web site: http://www.ixsbio.com/
Copyright